Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: TRI

Clinical Trial of Arcade Therapeutics' Flagship Therapeutic Mobile Game, StarStarter Rx, Shows Robust Reductions in Social Anxiety in Adults

NEW YORK, March 23, 2023 /PRNewswire/ -- Arcade Therapeutics (fka Wise Therapeutics) announced topline results of their StarStarter Rx Pilot Study, evaluating the efficacy and safety of their flagship digital therapeutic in adults 22-65 with Social Anxiety Disorder (SAD). The study achieved its predefined efficacy outcome for its primary endpoint, the Liebowitz Social Anxiety Scale (LSAS), as well as secondary and exploratory outcome measures such as the Beck Depression Inventory (BDI-II). No serious adverse events were reported.

Clinical Trial of Arcade Therapeutics' Flagship Therapeutic Mobile Game Shows Robust Reductions in Social Anxiety

These results build off of 7 randomized controlled trials that have already validated Arcade's proprietary, gamified approach to the cognitive training technique Attention Bias Modification. Arcade's clinical research uses a gold-standard placebo sham in research studies that isolates and controls for the therapy's mechanism of action.

"SAD is the most prevalent of anxiety disorders, more than twice that of Generalized Anxiety Disorder, with cases rising as many are now re-acclimating to social situations after the isolation of the pandemic. Indeed, almost 15 million people in the US, or 7% of the US population, are affected by SAD every year," said Arcade Chief Science Officer, Tracy Dennis-Tiwary PhD. "We are thrilled by these promising results as we continue down the path toward FDA submission of StarStarter Rx as the first game-based treatment for Social Anxiety Disorder."

"We're elated to have further improved our clinical impact with an even more engaging gameplay experience," said Arcade's Chief Executive Officer, Raj Amin. "We now look forward to working with healthcare partners to offer this safe and effective treatment option to patients in need."

StarStarter Rx is available with the Arcade Connect DTx deployment platform, which includes integration features, clinical assessments, and HIPAA-consent management. For more information see https://arcadetherapeutics.com/partners/.

Claims made above have not been evaluated by the Food and Drug Administration. StarStarter Rx is not intended for use as a standalone therapy and does not represent a substitution for your medication. You should consult your healthcare provider before using StarStarter Rx.

StarStarter Rx is made available without a prescription under FDA's enforcement policy for digital health devices for treating psychiatric disorders during the COVID-19 public health emergency (Document Number: 20023). For more information, please contact Arcade Therapeutics, Inc.


Arcade Therapeutics combines clinical neuroscience with mobile gaming to develop engaging, clinically validated digital therapeutics that address pervasive mental health challenges. Arcade Therapeutics' mission is to have a powerful, positive impact on the global mental health crisis through digital therapies that lower barriers to access and are as engaging as they are clinically effective.

Media Contact:
Nayan Ghosh
[email protected]

SOURCE Arcade Therapeutics Inc.

These press releases may also interest you

at 11:00
The prevalence of diabetic retinopathy has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of diabetic retinopathy and the growing research and development activities to develop...

at 11:00
Intraocular lenses are predominantly used to replace the natural eye lens of individuals with cataract. This ocular condition causes the natural eye lens to lose its transparency or become cloudy, causing blurry vision and other issues. Intraocular...

at 10:45
Cardiovascular diseases affect millions of people worldwide. Heart failure and cardiac arrest have emerged as grave concerns, with the highest mortality rates globally. These conditions are indeed posing a threat to our lives and need utmost...

at 10:41
OPSEU/SEFPO hospital professionals from Local 106 at London Health Sciences Centre will be holding rallies on May 29 to speak out against healthcare privatization and to achieve fairness for hospital professionals. Today's rallies will be one of...

at 10:40
OPSEU/SEFPO hospital professionals from Local 715 will be holding a rally on May 29 to speak out against healthcare privatization and to achieve fairness for hospital professionals. Today's rally will be one of numerous solidarity actions held across...

at 10:30
Joint injuries, aches, and other related disorders affect the quality of life of the masses. These issues prevent individuals from performing several activities and impact their natural mobility. Some disorders may be treated by medications or...

News published on and distributed by: